17:20 , Mar 2, 2018 |  BC Week In Review  |  Clinical News

University of Birmingham reports Phase I data for leukemia vaccine

Researchers at the University of Birmingham (Birmingham, U.K.) reported data from a Phase I trial in 9 healthy volunteers showing that escalating doses of leukemia candidate pDOM-HA-1 boosted with a modified vaccinia Ankara virus (MVA)...
04:21 , Dec 9, 2017 |  BioCentury  |  Product Development

Multimodal meeting

This year’s clinical abstracts at the American Society of Hematology meeting hint at how newer treatment modalities -- cell therapies in cancer and gene therapies in hematology -- will branch out into new indications and...